MissionIR Articles
-
AeternaZentaris (AEZS) Presents at Rodman & Renshaw Conference
AeternaZentaris, Inc. (NASDAQ: AEZS) is a specialty biopharmaceutical company engaged in the development and commercialization of novel treatments in the fields of oncology, endocrinology and women’s health. The company’s product pipeline includes Macrilen™, which is…
-
Aemetis (AMTX) Presents at Rodman & Renshaw Conference
Aemetis, Inc. (NASDAQ: AMTX) is an advanced renewable fuels and renewable chemicals company focused on the acquisition, development and commercialization of innovative technologies that replace traditional petroleum-based products. The company currently owns and operates a…
-
ADMA Biologics (ADMA) Presents at Rodman & Renshaw Conference
ADMA Biologics, Inc. (NASDAQ: ADMA) is a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty plasma-based biologics for the treatment and prevention of primary immune deficiency disorder (PIDD) and certain infectious diseases.…
-
Actinium Pharmaceuticals (ATNM) Presents at Rodman & Renshaw Conference
Actinium Pharmaceuticals, Inc. (NYSE: ANTM) is a biopharmaceutical company focused on the development of cancer drugs. The company’s product candidates are based on its patented technology, which combines the cancer targeting precision of monoclonal antibodies…
-
Acme United (ACU) Presents at Rodman & Renshaw Conference
Acme United Corporation (NYSE: ACU) is a worldwide supplier of innovative cutting, measuring and safety products to the school, home, office, hardware, sporting goods and industrial markets. The company sells its products under a collection…
-
AcelRx Pharmaceuticals (ACRX) Presents at Rodman & Renshaw Conference
AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute pain. The company’s leading product candidate, Zalviso™, is designed for the…
-
International Stem Cell Corp. (ISCO) Begins Next Phase of Research Collaboration with Rohto Pharmaceutical Co., Ltd. of Japan
Today before the opening bell, International Stem Cell Corp. announced that it has entered into the second phase of the existing Research Agreement with Rohto Pharmaceutical Co., Ltd. (“Rohto”), a global Japanese pharmaceutical company recognized…
-
Accurexa (ACXA) Presents at Rodman & Renshaw Conference
Accurexa, Inc. (OTCQB: ACXA) is focused on the development and commercialization of novel neurological therapies. The company’s propriety BranchPoint device was invented to deliver therapeutics, such as stem cells or gene therapy vectors, through the…
-
Abeona Therapeutics (ABEO) Presents at Rodman & Renshaw Conference
Abeona Therapeutics, Inc. (NASDAQ: ABEO) develops and delivers gene therapy and plasma-based products for severe and life-threatening diseases. The company’s lead programs are ABO-101 and ABO-102, which are adeno-associated virus-based gene therapies for the treatment…
-
22nd Century Group (XXII) Presents at Rodman & Renshaw Conference
22nd Century Group, Inc. (NYSE MKT: XXII) is a plant biotechnology company focused on the development of technology that permits the management of nicotine levels in tobacco plants through genetic engineering and plant breeding. The…
-
Why ENGlobal Corp. (ENG) Warrants a Second Glance as Small-Cap Investment Option
Houston-based ENGlobal (NASDAQ:ENG) is a specialty engineering firm charting its path to become a preferred provider of innovative automation integration services and select EPCM (engineering, procurement and construction management) projects worldwide. The company is specifically…
-
Digital Power Corp. (DPW) Addressing Demanding Market Applications with High-Grade Power System Solutions
Digital Power designs, develops, manufactures and sells high-grade customized and off-the-shelf power system solutions for the most demanding applications in the medical, military, telecom and industrial markets. In July, the company unveiled its newest family…
-
International Stem Cell Corp. (ISCO) CSO to Present at Upcoming Rodman and Renshaw
International Stem Cell (OTCQB: ISCO), a California-based biotechnology company developing novel stem cell-based therapies and biomedical products, this morning announced that company board member and Chief Scientific Officer Ruslan Semechkin, PhD, will present at the…
Search Articles
Latest Articles
- A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ) Advancing Retail Innovation Through AI-Powered Smart-Cart Technology
- Forward Industries Inc. (NASDAQ: FWDI) Positive Update for Shareholders After Debuting the Company’s Solana Treasury Strategy
- Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Secures Funding to Strengthen North American Supply Chain
- MissionIRNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Featured in BioMedWire Editorial on Rare Disease Therapies
- MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Talks Bold Strategy to Treat GBM in BioMedWire Podcast